ProJenX launches to advance novel, targeted therapies for ALS and other brain diseases
/PRNewswire/ -- ProJenX, a New York City-based, clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined...
Source: prnewswire.com